Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achiev...
Gespeichert in:
Veröffentlicht in: | Public health (London) 2021-12, Vol.201, p.98-107 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 107 |
---|---|
container_issue | |
container_start_page | 98 |
container_title | Public health (London) |
container_volume | 201 |
creator | Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J.R. Durrant, L. Avery, T. Ball, J.K. Barker, C. Bennett, R. McKeever, T. Vedhara, K. |
description | Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level.
& Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public.
The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination. |
doi_str_mv | 10.1016/j.puhe.2021.10.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0033350621004121</els_id><sourcerecordid>2600821889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-4ac792ca6336f37e27ca70aa80e37916458ba0bb51e886eb32e289e6217c26033</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EotvCH-CALHHhkmVsJ46DEBJaClSq1AvlajnO7K5XWTvYSUT_PQ5bKuDAyfLM9954_Ah5wWDNgMk3h_Uw7XHNgbNcWAPIR2TFyloWlWTyMVkBCFGICuQZOU_pAAC8FtVTciZKBUyVYkWGW99hTKPxnfM7mg9qui5iSst1NtY6j3SPyWXE3lHn6bhHaoMf8cdIw5Zubr5dfSxY85Z2OGMfhiP6Xw1DO7fLsj6LRoxzLrvgn5EnW9MnfH5_XpDbT5dfN1-K65vPV5sP14UtlRiL0ti64dZIIeRW1Mhra2owRgGKumGyrFRroG0rhkpJbAVHrhqUnNWWy7z3BXl_8h2m9oidzdOj6fUQ3dHEOx2M0393vNvrXZi1qjgoVWWD1_cGMXyfMI366JLFvjcew5R0ngKKM6WajL76Bz2EKfq8XqY4V6xisFD8RNkYUoq4fXgMA70Eqg96CVQvgS61HGgWvfxzjQfJ7wQz8O4EYP7M2WHUyTr0FjsX0Y66C-5__j8Bc_2yWg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622815109</pqid></control><display><type>article</type><title>Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Knight, H. ; Jia, R. ; Ayling, K. ; Bradbury, K. ; Baker, K. ; Chalder, T. ; Morling, J.R. ; Durrant, L. ; Avery, T. ; Ball, J.K. ; Barker, C. ; Bennett, R. ; McKeever, T. ; Vedhara, K.</creator><creatorcontrib>Knight, H. ; Jia, R. ; Ayling, K. ; Bradbury, K. ; Baker, K. ; Chalder, T. ; Morling, J.R. ; Durrant, L. ; Avery, T. ; Ball, J.K. ; Barker, C. ; Bennett, R. ; McKeever, T. ; Vedhara, K.</creatorcontrib><description>Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level.
& Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public.
The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.</description><identifier>ISSN: 0033-3506</identifier><identifier>EISSN: 1476-5616</identifier><identifier>DOI: 10.1016/j.puhe.2021.10.006</identifier><identifier>PMID: 34801843</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Behavior change ; Context ; Coronaviruses ; COVID-19 ; COVID-19 Vaccines ; Digitization ; Disease transmission ; Dissemination ; Experts ; Humans ; Immunization ; Immunology ; Intervention ; Interviews ; Literature reviews ; Motivational interviewing ; Original Research ; Pandemics ; Population studies ; Public health ; Public participation ; SARS-CoV-2 ; Self-efficacy ; Severe acute respiratory syndrome coronavirus 2 ; Uptake ; Vaccination ; Vaccination Hesitancy ; Vaccine hesitancy ; Vaccines ; Viral diseases ; Workshops</subject><ispartof>Public health (London), 2021-12, Vol.201, p.98-107</ispartof><rights>2021 The Royal Society for Public Health</rights><rights>Copyright © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Dec 2021</rights><rights>2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. 2021 The Royal Society for Public Health</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-4ac792ca6336f37e27ca70aa80e37916458ba0bb51e886eb32e289e6217c26033</citedby><cites>FETCH-LOGICAL-c483t-4ac792ca6336f37e27ca70aa80e37916458ba0bb51e886eb32e289e6217c26033</cites><orcidid>0000-0001-6843-8250 ; 0000-0002-4602-3238 ; 0000-0001-8263-4151 ; 0000-0003-0775-1045</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0033350621004121$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,30976,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34801843$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Knight, H.</creatorcontrib><creatorcontrib>Jia, R.</creatorcontrib><creatorcontrib>Ayling, K.</creatorcontrib><creatorcontrib>Bradbury, K.</creatorcontrib><creatorcontrib>Baker, K.</creatorcontrib><creatorcontrib>Chalder, T.</creatorcontrib><creatorcontrib>Morling, J.R.</creatorcontrib><creatorcontrib>Durrant, L.</creatorcontrib><creatorcontrib>Avery, T.</creatorcontrib><creatorcontrib>Ball, J.K.</creatorcontrib><creatorcontrib>Barker, C.</creatorcontrib><creatorcontrib>Bennett, R.</creatorcontrib><creatorcontrib>McKeever, T.</creatorcontrib><creatorcontrib>Vedhara, K.</creatorcontrib><title>Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention</title><title>Public health (London)</title><addtitle>Public Health</addtitle><description>Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level.
& Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public.
The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.</description><subject>Behavior change</subject><subject>Context</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 Vaccines</subject><subject>Digitization</subject><subject>Disease transmission</subject><subject>Dissemination</subject><subject>Experts</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunology</subject><subject>Intervention</subject><subject>Interviews</subject><subject>Literature reviews</subject><subject>Motivational interviewing</subject><subject>Original Research</subject><subject>Pandemics</subject><subject>Population studies</subject><subject>Public health</subject><subject>Public participation</subject><subject>SARS-CoV-2</subject><subject>Self-efficacy</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Uptake</subject><subject>Vaccination</subject><subject>Vaccination Hesitancy</subject><subject>Vaccine hesitancy</subject><subject>Vaccines</subject><subject>Viral diseases</subject><subject>Workshops</subject><issn>0033-3506</issn><issn>1476-5616</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNp9kUFv1DAQhS0EotvCH-CALHHhkmVsJ46DEBJaClSq1AvlajnO7K5XWTvYSUT_PQ5bKuDAyfLM9954_Ah5wWDNgMk3h_Uw7XHNgbNcWAPIR2TFyloWlWTyMVkBCFGICuQZOU_pAAC8FtVTciZKBUyVYkWGW99hTKPxnfM7mg9qui5iSst1NtY6j3SPyWXE3lHn6bhHaoMf8cdIw5Zubr5dfSxY85Z2OGMfhiP6Xw1DO7fLsj6LRoxzLrvgn5EnW9MnfH5_XpDbT5dfN1-K65vPV5sP14UtlRiL0ti64dZIIeRW1Mhra2owRgGKumGyrFRroG0rhkpJbAVHrhqUnNWWy7z3BXl_8h2m9oidzdOj6fUQ3dHEOx2M0393vNvrXZi1qjgoVWWD1_cGMXyfMI366JLFvjcew5R0ngKKM6WajL76Bz2EKfq8XqY4V6xisFD8RNkYUoq4fXgMA70Eqg96CVQvgS61HGgWvfxzjQfJ7wQz8O4EYP7M2WHUyTr0FjsX0Y66C-5__j8Bc_2yWg</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Knight, H.</creator><creator>Jia, R.</creator><creator>Ayling, K.</creator><creator>Bradbury, K.</creator><creator>Baker, K.</creator><creator>Chalder, T.</creator><creator>Morling, J.R.</creator><creator>Durrant, L.</creator><creator>Avery, T.</creator><creator>Ball, J.K.</creator><creator>Barker, C.</creator><creator>Bennett, R.</creator><creator>McKeever, T.</creator><creator>Vedhara, K.</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><general>The Royal Society for Public Health. Published by Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6843-8250</orcidid><orcidid>https://orcid.org/0000-0002-4602-3238</orcidid><orcidid>https://orcid.org/0000-0001-8263-4151</orcidid><orcidid>https://orcid.org/0000-0003-0775-1045</orcidid></search><sort><creationdate>20211201</creationdate><title>Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention</title><author>Knight, H. ; Jia, R. ; Ayling, K. ; Bradbury, K. ; Baker, K. ; Chalder, T. ; Morling, J.R. ; Durrant, L. ; Avery, T. ; Ball, J.K. ; Barker, C. ; Bennett, R. ; McKeever, T. ; Vedhara, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-4ac792ca6336f37e27ca70aa80e37916458ba0bb51e886eb32e289e6217c26033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Behavior change</topic><topic>Context</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 Vaccines</topic><topic>Digitization</topic><topic>Disease transmission</topic><topic>Dissemination</topic><topic>Experts</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunology</topic><topic>Intervention</topic><topic>Interviews</topic><topic>Literature reviews</topic><topic>Motivational interviewing</topic><topic>Original Research</topic><topic>Pandemics</topic><topic>Population studies</topic><topic>Public health</topic><topic>Public participation</topic><topic>SARS-CoV-2</topic><topic>Self-efficacy</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Uptake</topic><topic>Vaccination</topic><topic>Vaccination Hesitancy</topic><topic>Vaccine hesitancy</topic><topic>Vaccines</topic><topic>Viral diseases</topic><topic>Workshops</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knight, H.</creatorcontrib><creatorcontrib>Jia, R.</creatorcontrib><creatorcontrib>Ayling, K.</creatorcontrib><creatorcontrib>Bradbury, K.</creatorcontrib><creatorcontrib>Baker, K.</creatorcontrib><creatorcontrib>Chalder, T.</creatorcontrib><creatorcontrib>Morling, J.R.</creatorcontrib><creatorcontrib>Durrant, L.</creatorcontrib><creatorcontrib>Avery, T.</creatorcontrib><creatorcontrib>Ball, J.K.</creatorcontrib><creatorcontrib>Barker, C.</creatorcontrib><creatorcontrib>Bennett, R.</creatorcontrib><creatorcontrib>McKeever, T.</creatorcontrib><creatorcontrib>Vedhara, K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Public health (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knight, H.</au><au>Jia, R.</au><au>Ayling, K.</au><au>Bradbury, K.</au><au>Baker, K.</au><au>Chalder, T.</au><au>Morling, J.R.</au><au>Durrant, L.</au><au>Avery, T.</au><au>Ball, J.K.</au><au>Barker, C.</au><au>Bennett, R.</au><au>McKeever, T.</au><au>Vedhara, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention</atitle><jtitle>Public health (London)</jtitle><addtitle>Public Health</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>201</volume><spage>98</spage><epage>107</epage><pages>98-107</pages><issn>0033-3506</issn><eissn>1476-5616</eissn><abstract>Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level.
& Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public.
The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>34801843</pmid><doi>10.1016/j.puhe.2021.10.006</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-6843-8250</orcidid><orcidid>https://orcid.org/0000-0002-4602-3238</orcidid><orcidid>https://orcid.org/0000-0001-8263-4151</orcidid><orcidid>https://orcid.org/0000-0003-0775-1045</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3506 |
ispartof | Public health (London), 2021-12, Vol.201, p.98-107 |
issn | 0033-3506 1476-5616 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520885 |
source | Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Behavior change Context Coronaviruses COVID-19 COVID-19 Vaccines Digitization Disease transmission Dissemination Experts Humans Immunization Immunology Intervention Interviews Literature reviews Motivational interviewing Original Research Pandemics Population studies Public health Public participation SARS-CoV-2 Self-efficacy Severe acute respiratory syndrome coronavirus 2 Uptake Vaccination Vaccination Hesitancy Vaccine hesitancy Vaccines Viral diseases Workshops |
title | Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T14%3A42%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20and%20addressing%20vaccine%20hesitancy%20in%20the%20context%20of%20COVID-19:%20development%20of%20a%20digital%20intervention&rft.jtitle=Public%20health%20(London)&rft.au=Knight,%20H.&rft.date=2021-12-01&rft.volume=201&rft.spage=98&rft.epage=107&rft.pages=98-107&rft.issn=0033-3506&rft.eissn=1476-5616&rft_id=info:doi/10.1016/j.puhe.2021.10.006&rft_dat=%3Cproquest_pubme%3E2600821889%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622815109&rft_id=info:pmid/34801843&rft_els_id=S0033350621004121&rfr_iscdi=true |